Executive Development Programme in Artificial Intelligence for Drug Development Applications

-- ViewingNow

The Executive Development Programme in Artificial Intelligence (AI) for Drug Development Applications is a certificate course aimed at equipping learners with essential skills to advance their careers in the rapidly evolving field of AI and drug development. This programme highlights the importance of AI in transforming drug discovery, development, and delivery, and addresses the growing industry demand for professionals with expertise in AI applications for drug development.

4.5
Based on 3,553 reviews

2,812+

Students enrolled

GBP £ 140

GBP £ 202

Save 44% with our special offer

Start Now

ๅ…ณไบŽ่ฟ™้—จ่ฏพ็จ‹

Through a combination of theoretical knowledge and practical application, learners will gain hands-on experience in leveraging AI tools and techniques to optimize drug development processes, improve drug safety and efficacy, and reduce time-to-market. By successfully completing this programme, learners will be well-positioned to drive AI-driven innovation in their organizations and contribute to the development of life-saving therapies for patients worldwide.

100%ๅœจ็บฟ

้šๆ—ถ้šๅœฐๅญฆไน 

ๅฏๅˆ†ไบซ็š„่ฏไนฆ

ๆทปๅŠ ๅˆฐๆ‚จ็š„LinkedInไธชไบบ่ต„ๆ–™

2ไธชๆœˆๅฎŒๆˆ

ๆฏๅ‘จ2-3ๅฐๆ—ถ

้šๆ—ถๅผ€ๅง‹

ๆ— ็ญ‰ๅพ…ๆœŸ

่ฏพ็จ‹่ฏฆๆƒ…

โ€ข Introduction to Artificial Intelligence (AI): Understanding AI, its types, and capabilities
โ€ข AI in Drug Development: Overview of AI applications in drug discovery and development
โ€ข Machine Learning (ML) for Drug Discovery: Utilizing ML algorithms to predict drug-like properties and interactions
โ€ข Deep Learning (DL) Techniques in Drug Development: Leveraging DL models for structure-based drug design and generative models
โ€ข Natural Language Processing (NLP) for Pharmacovigilance: Applying NLP techniques for drug safety and adverse event monitoring
โ€ข AI-driven Clinical Trials: Streamlining patient recruitment and trial design with AI
โ€ข AI Ethics and Regulations: Exploring ethical considerations, regulatory compliance, and data privacy in AI-driven drug development
โ€ข Future Perspectives: Examining emerging AI trends and their impact on the pharmaceutical industry

่Œไธš้“่ทฏ

ๅ…ฅๅญฆ่ฆๆฑ‚

  • ๅฏนไธป้ข˜็š„ๅŸบๆœฌ็†่งฃ
  • ่‹ฑ่ฏญ่ฏญ่จ€่ƒฝๅŠ›
  • ่ฎก็ฎ—ๆœบๅ’Œไบ’่”็ฝ‘่ฎฟ้—ฎ
  • ๅŸบๆœฌ่ฎก็ฎ—ๆœบๆŠ€่ƒฝ
  • ๅฎŒๆˆ่ฏพ็จ‹็š„ๅฅ‰็Œฎ็ฒพ็ฅž

ๆ— ้œ€ไบ‹ๅ…ˆ็š„ๆญฃๅผ่ต„ๆ ผใ€‚่ฏพ็จ‹่ฎพ่ฎกๆณจ้‡ๅฏ่ฎฟ้—ฎๆ€งใ€‚

่ฏพ็จ‹็Šถๆ€

ๆœฌ่ฏพ็จ‹ไธบ่Œไธšๅ‘ๅฑ•ๆไพ›ๅฎž็”จ็š„็Ÿฅ่ฏ†ๅ’ŒๆŠ€่ƒฝใ€‚ๅฎƒๆ˜ฏ๏ผš

  • ๆœช็ป่ฎคๅฏๆœบๆž„่ฎค่ฏ
  • ๆœช็ปๆŽˆๆƒๆœบๆž„็›‘็ฎก
  • ๅฏนๆญฃๅผ่ต„ๆ ผ็š„่กฅๅ……

ๆˆๅŠŸๅฎŒๆˆ่ฏพ็จ‹ๅŽ๏ผŒๆ‚จๅฐ†่Žทๅพ—็ป“ไธš่ฏไนฆใ€‚

ไธบไป€ไนˆไบบไปฌ้€‰ๆ‹ฉๆˆ‘ไปฌไฝœไธบ่Œไธšๅ‘ๅฑ•

ๆญฃๅœจๅŠ ่ฝฝ่ฏ„่ฎบ...

ๅธธ่ง้—ฎ้ข˜

ๆ˜ฏไป€ไนˆ่ฎฉ่ฟ™้—จ่ฏพ็จ‹ไธŽๅ…ถไป–่ฏพ็จ‹ไธๅŒ๏ผŸ

ๅฎŒๆˆ่ฏพ็จ‹้œ€่ฆๅคš้•ฟๆ—ถ้—ด๏ผŸ

WhatSupportWillIReceive

IsCertificateRecognized

WhatCareerOpportunities

ๆˆ‘ไป€ไนˆๆ—ถๅ€™ๅฏไปฅๅผ€ๅง‹่ฏพ็จ‹๏ผŸ

่ฏพ็จ‹ๆ ผๅผๅ’Œๅญฆไน ๆ–นๆณ•ๆ˜ฏไป€ไนˆ๏ผŸ

่ฏพ็จ‹่ดน็”จ

ๆœ€ๅ—ๆฌข่ฟŽ
ๅฟซ้€Ÿ้€š้“๏ผš GBP £140
1ไธชๆœˆๅ†…ๅฎŒๆˆ
ๅŠ ้€Ÿๅญฆไน ่ทฏๅพ„
  • ๆฏๅ‘จ3-4ๅฐๆ—ถ
  • ๆๅ‰่ฏไนฆไบคไป˜
  • ๅผ€ๆ”พๆณจๅ†Œ - ้šๆ—ถๅผ€ๅง‹
Start Now
ๆ ‡ๅ‡†ๆจกๅผ๏ผš GBP £90
2ไธชๆœˆๅ†…ๅฎŒๆˆ
็ตๆดปๅญฆไน ่Š‚ๅฅ
  • ๆฏๅ‘จ2-3ๅฐๆ—ถ
  • ๅธธ่ง„่ฏไนฆไบคไป˜
  • ๅผ€ๆ”พๆณจๅ†Œ - ้šๆ—ถๅผ€ๅง‹
Start Now
ไธคไธช่ฎกๅˆ’้ƒฝๅŒ…ๅซ็š„ๅ†…ๅฎน๏ผš
  • ๅฎŒๆ•ด่ฏพ็จ‹่ฎฟ้—ฎ
  • ๆ•ฐๅญ—่ฏไนฆ
  • ่ฏพ็จ‹ๆๆ–™
ๅ…จๅŒ…ๅฎšไปท โ€ข ๆ— ้š่—่ดน็”จๆˆ–้ขๅค–่ดน็”จ

่Žทๅ–่ฏพ็จ‹ไฟกๆฏ

ๆˆ‘ไปฌๅฐ†ๅ‘ๆ‚จๅ‘้€่ฏฆ็ป†็š„่ฏพ็จ‹ไฟกๆฏ

ไปฅๅ…ฌๅธ่บซไปฝไป˜ๆฌพ

ไธบๆ‚จ็š„ๅ…ฌๅธ็”ณ่ฏทๅ‘็ฅจไปฅๆ”ฏไป˜ๆญค่ฏพ็จ‹่ดน็”จใ€‚

้€š่ฟ‡ๅ‘็ฅจไป˜ๆฌพ

่Žทๅพ—่Œไธš่ฏไนฆ

็คบไพ‹่ฏไนฆ่ƒŒๆ™ฏ
EXECUTIVE DEVELOPMENT PROGRAMME IN ARTIFICIAL INTELLIGENCE FOR DRUG DEVELOPMENT APPLICATIONS
ๆŽˆไบˆ็ป™
ๅญฆไน ่€…ๅง“ๅ
ๅทฒๅฎŒๆˆ่ฏพ็จ‹็š„ไบบ
London School of Business and Administration (LSBA)
ๆŽˆไบˆๆ—ฅๆœŸ
05 May 2025
ๅŒบๅ—้“พID๏ผš s-1-a-2-m-3-p-4-l-5-e
ๅฐ†ๆญค่ฏไนฆๆทปๅŠ ๅˆฐๆ‚จ็š„LinkedInไธชไบบ่ต„ๆ–™ใ€็ฎ€ๅކๆˆ–CVไธญใ€‚ๅœจ็คพไบคๅช’ไฝ“ๅ’Œ็ปฉๆ•ˆ่ฏ„ไผฐไธญๅˆ†ไบซๅฎƒใ€‚
SSB Logo

4.8
ๆ–ฐๆณจๅ†Œ